Catalent’s Somerset site is home to our early phase development expertise, focusing on preclinical to clinical phase 2 formulation, analytical, and manufacturing solutions for orally delivered small molecules. We are excited to share our new and expanded hot melt extrusion capabilities with you!
Our hot melt extrusion capabilities at our Somerset facility allow for method development and easy scale-up for your poorly soluble compound. Come join Ron Vladyka, Director, R&D Manufacturing, for a tour and discussion on our expanded hot melt extrusion capabilities.
To celebrate, you are invited to attend our breakfast and tour event.
Date: Friday, April 12, 2019
Time: 9:00am- 12:00pm
- 9:00am Arrival and refreshments
- 9:15am Welcome address
- 9:30am Breakfast
- 10:30am Tour of facility
- 11:30am Departing comments
- 11:45am Departure
Please RSVP by April 11, 2019.